Pseudomonas aeruginosa genome sequencing and assembly

Investigation of ceftazidime-avibactam and comparator drugs activity against Pseudomonas aeruginosa clinical isolates collected from five centres distributed across South Italy from October 2022 to April 2023, and NGS-based characterisation of the beta-lactamase profiles and clonal relatedness of a MDR strains selection.